Terms: = Pancreatic cancer AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1 AND Treatment
4 results:
1. Genetic Susceptibility in Understanding of pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium.
Vodickova L; Horak J; Vodicka P
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):942-948. PubMed ID: 35506247
[TBL] [Abstract] [Full Text] [Related]
2. Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in pancreatic cancer.
Ye Z; Zhu Z; Xie J; Feng Z; Li Y; Xu X; Li W; Chen W
Int J Nanomedicine; 2020; 15():9859-9873. PubMed ID: 33324055
[TBL] [Abstract] [Full Text] [Related]
3. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls.
Pedersen KS; Bamlet WR; Oberg AL; de Andrade M; Matsumoto ME; Tang H; Thibodeau SN; Petersen GM; Wang L
PLoS One; 2011 Mar; 6(3):e18223. PubMed ID: 21455317
[TBL] [Abstract] [Full Text] [Related]
4. Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
Raida M; Kliche KO; Schwabe W; Häusler P; Clement JH; Behnke D; Höffken K
J Cancer Res Clin Oncol; 2002 Feb; 128(2):96-102. PubMed ID: 11862480
[TBL] [Abstract] [Full Text] [Related]
